Drug Shortage Report for DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML
| Report ID | 179482 |
| Drug Identification Number | 00664227 |
| Brand name | DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML |
| Common or Proper name | DEXAMETHASONE 4MG/ML |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE PHOSPHATE |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR |
| Packaging size | 5ML |
| ATC code | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-14 |
| Estimated end date | 2023-01-20 |
| Actual end date | 2023-01-18 |
| Shortage status | Resolved |
| Updated date | 2023-01-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-01-19 | French | Compare |
| v3 | 2023-01-19 | English | Compare |
| v2 | 2022-12-28 | French | Compare |
| v1 | 2022-12-28 | English | Compare |
Showing 1 to 4 of 4